With another successful DIA Annual Meeting behind us, as well as some time to reflect, we wanted to thank our industry partners and colleagues for making this year’s meeting one of the best yet. We also want to highlight some of the thought-provoking work and innovations that raised the already high bar. Here goes.
- We know that the concept of patient centricity has been center stage for years now but during this year’s meeting we saw firsthand the compelling early data presented by companies like Roche and Sanofi about how adopting a truly patient-centric approach throughout the development and implementation of a study can positively impact study timelines. Putting some hard numbers around the concept can really help to illustrate how, when put into practice, a patient-centric approach can make a difference. We addressed this theme during our own Innovation Theater talk with the Michael J. Fox Foundation and the Diabetes Collective, and agree that data can and should be used to continue to move patient centricity forward.
- Another interesting takeaway we noted was the new – and renewed – collaborations between advocacy groups and pharmaceutical companies – especially pertaining to rare disease, where patient recruitment for clinical trials can be particularly challenging. It is these types of collaborations that will continue to help our industry evolve as together we strive to improve recruitment processes.
- Finally, we heard Melissa Hogan, President of Saving Case and Friends, say that she prefers “Patient Partners” over “patient-centric”. We love this idea and agree it speaks to what so many of us are doing to put patients at the center of clinical research.
For more on patient centricity and why it matters now more than ever download our free eBook, follow us on Twitter @BBKWorldwide and continue to visit our blog regularly.